TRAITEMENT DU CANCER DU SANG
- 专利权人:
- THRESHOLD PHARMACEUTICALS; INC.
- 发明人:
- CURD, JOHN,HANDISIDES, DAMIAN,HART, CHARLES,KROLL, STEWART
- 申请号：
- CA2803113
- 公开号：
- CA2803113A1
- 申请日:
- 2011.06.27
- 申请国别(地区):
- CA
- 年份:
- 2012
- 代理人:
- 摘要：
- Hypoxia activated prodrugs, such as, e.g., TH-281, TH-302, and TH-308, are useful for the treatment of various blood cancers, such as acute leukemias, chronic leukemias, MDS, MF, and multiple myeloma.
- 来源网站：
- 中国工程科技知识中心
